National Center for Complementary & Integrative Health; Notice of Closed Meeting, 105062-105063 [2024-30707]
Download as PDF
<![CDATA[
105062
Federal Register / Vol. 89, No. 247 / Thursday, December 26, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications
and contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP 2A:
SBIR Review Meeting.
Date: February 24, 2025.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health
Scientist Administrator, Division of
Extramural Activities, Program and Review
Extramural Staff Training Office, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W534, Rockville, Maryland
20850, 240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–4:
SBIR Contract Review Meeting.
Date: February 25–26, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, Division of
Extramural Activities, Program and Review
Extramural Staff Training Office, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W238, Rockville, Maryland
20850, 240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP 2B:
SBIR Review Meeting.
Date: February 25, 2025.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
VerDate Sep<11>2014
19:37 Dec 23, 2024
Jkt 265001
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health
Scientist Administrator, Division of
Extramural Activities, Program and Review
Extramural Staff Training Office, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W534, Rockville, Maryland
20850, 240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP 5A:
SBIR Review Meeting.
Date: March 3, 2025.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health
Scientist Administrator, Division of
Extramural Activities, Program and Review
Extramural Staff Training Office, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W534, Rockville, Maryland
20850, 240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP 5B:
SBIR Review Meeting.
Date: March 4, 2025.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health
Scientist Administrator, Division of
Extramural Activities, Program and Review
Extramural Staff Training Office, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W534, Rockville, Maryland
20850, 240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Molecular and Cellular Analysis
Technologies.
Date: March 4–5, 2025.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W246, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Rockville, Maryland 20850,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Assay
Validation of High-Quality Markers for
Clinical Studies in Cancer (UH2/UH3).
Date: March 5, 2025.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W552, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Xiaozhong Alex Bao,
Ph.D., Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W552, Rockville, Maryland 20850,
240–276–5070, Baox@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Translational Research Toward Development
of a Kaposi Sarcoma Herpesvirus (KSHV)
Vaccine.
Date: March 11, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W634, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Michael E. Lindquist,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W634, Rockville, Maryland 20850,
mike.lindquist@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 18, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–30711 Filed 12–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\26DEN1.SGM
26DEN1
105063
Federal Register / Vol. 89, No. 247 / Thursday, December 26, 2024 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Investigator
Initiated Clinical Trials of Complementary
and Integrative Interventions Delivered
Remotely or via mHealth (R01 Clinical Trial
Required).
Date: January 30, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for
Complementary and Integrative, 6707
Democracy Blvd., Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Marta V. Hamity, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20892,
marta.hamity@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: December 18, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30707 Filed 12–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–7080–N–62; OMB Control
No.: 2501–0038]
30-Day Notice of Proposed Information
Collection; OCHCO Personnel Security
Integrated System for Tracking
(PerSIST)
Office of Policy Development
and Research, Chief Data Officer, HUD.
AGENCY:
Information collection
Number of
respondents
Notice.
HUD is seeking approval from
the Office of Management and Budget
(OMB) for the information collection
described below. In accordance with the
Paperwork Reduction Act, HUD is
requesting comment from all interested
parties on the proposed collection of
information. The purpose of this notice
is to allow for an additional 30 days of
public comment.
DATES: Comments Due Date: January 27,
2025.
ADDRESSES: Interested persons are
invited to submit comments regarding
this proposal. Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Interested persons are
also invited to submit comments
regarding this proposal by name and/or
OMB Control Number and should be
sent to: Anna Guido, Clearance Officer,
REE, Department of Housing and Urban
Development, 451 7th Street SW, Room
8210, Washington, DC 20410–5000;
telephone 202–402–5534 (this is not a
toll-free number).
FOR FURTHER INFORMATION CONTACT:
Anna Guido, Clearance Officer, REE,
Department of Housing and Urban
Development, 451 7th Street SW,
Washington, DC 20410; email
Anna.P.Guido@hud.gov, telephone 202–
402–5534. This is not a toll-free number.
HUD welcomes and is prepared to
receive calls from individuals who are
deaf or hard of hearing, as well as
SUMMARY:
Frequency of
response
Responses
per annum
Burden hour
per response
individuals with speech or
communication disabilities. To learn
more about how to make an accessible
telephone call, please visit https://
www.fcc.gov/consumers/guides/
telecommunications-relay-service-trs.
Copies of available documents
submitted to OMB may be obtained
from Ms. Guido.
This
notice informs the public that HUD is
seeking approval from OMB for the
information collection described in
Section A.
The Federal Register notice that
solicited public comment on the
information collection for a period of 60
days was published on October 15, 2024
at 89 FR 83034.
SUPPLEMENTARY INFORMATION:
A. Overview of Information Collection
Title of Information Collection:
OCHCO Personnel Security Integrated
System for Tracking (PerSIST); 22019
PIV Pre-Screen Application.
MB Approval Number: 2501–0038.
Type of Request: Extension of a
currently approved collection.
Form Number: HUD 22019.
Description of the need for the
information and proposed use: The PII
collected and maintained in PerSIST is
relevant and necessary to carrying out
the investigatory process used to
document and support decisions
regarding the suitability, eligibility, and
fitness for service of applicants for
federal employment and contract
positions, including long-term students,
interns, or volunteers to the extent that
their duties require access to federal
facilities, information, systems, or
applications.
Annual
burden hours
Hourly cost
per response
Annual cost
22019 PIV Pre-Screen
Application ................
1,625
1
1,625
.17
276.25
$43.77
$12,091.46
Total ......................
1,625
1
1,625
.17
276.25
43.77
12,091.46
B. Solicitation of Public Comment
ddrumheller on DSK120RN23PROD with NOTICES1
ACTION:
This notice is soliciting comments
from members of the public and affected
parties concerning the collection of
information described in Section A on
the following:
(1) Whether the proposed collection
of information is necessary for the
proper performance of the functions of
the agency, including whether the
information will have practical utility;
VerDate Sep<11>2014
19:37 Dec 23, 2024
Jkt 265001
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information;
(3) Ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) Ways to minimize the burden of
the collection of information on those
who are to respond; including through
the use of appropriate automated
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses.
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
(5) Ways to minimize the burden of
the collection of information on those
who are to respond, including the use
of automated collection techniques or
other forms of information technology.
HUD encourages interested parties to
submit comment in response to these
questions.
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 89, Number 247 (Thursday, December 26, 2024)]
[Notices]
[Pages 105062-105063]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30707]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Integrative Health; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 105063]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Integrative Health Special Emphasis Panel; Investigator Initiated
Clinical Trials of Complementary and Integrative Interventions
Delivered Remotely or via mHealth (R01 Clinical Trial Required).
Date: January 30, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Center for Complementary and Integrative, 6707
Democracy Blvd., Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Marta V. Hamity, Ph.D., Scientific Review
Officer, Office of Scientific Review, Division of Extramural
Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401,
Bethesda, MD 20892, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: December 18, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30707 Filed 12-23-24; 8:45 am]
BILLING CODE 4140-01-P
